Skip to main content
Clinical Trials/NCT03975517
NCT03975517
Completed
Not Applicable

Analysis of Sexual Risks in Prep (Pre-exposure Prophylaxis) Users Followed-up in a University Care Centre (Le Trait d'Union)

University Hospital, Strasbourg, France1 site in 1 country200 target enrollmentStarted: June 4, 2019Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
University Hospital, Strasbourg, France
Enrollment
200
Locations
1
Primary Endpoint
Analysis of sexual behavior in Prep users

Overview

Brief Summary

Primary purpose of the study: to describe sexual behavior of Prep users, whatever mode of intake, ie continuous or on-demand; it has been shown in some studies, an increase of sexual risks in Prep users, and therefore an similar increase of STIs (sexually transmitted diseases); using a self-questionnaire, we'd like to evaluate sexual behavior before, and 6 months after, starting Prep.

Secondary purposes: to describe medical characteristics of Prep users (past medical condition, demographic characteristics, vaccinations, kidney function, serological results, urine and anal/pharyngeal swabs), clinical and biological Prep safety, STIs occurrence, and antibiotic prescriptions, continuous or on-demand intake, Prep indication.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • non HIV-infected subjects
  • men aged 18 years or older
  • having non protected sexual relationship
  • taking Prep (emtricitable/tenofovir disoproxil fumarate) either every day, or on-demand
  • affiliated to social security
  • Exclusion criteria:
  • HIV-infected patients
  • refusal of study participation
  • not on Prep
  • not fluent in French language

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Analysis of sexual behavior in Prep users

Time Frame: 6 months

Sexual behavior will be evaluated with a questionnaire

Secondary Outcomes

  • Description of the medical profile of the Strasbourgeoise active file(6 months)

Investigators

Sponsor
University Hospital, Strasbourg, France
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials